Pathological ECM deposition by activated fibroblasts/myofibroblasts. Impairs organ function (liver cirrhosis, pulmonary fibrosis, cardiac remodelling). Anti-TGFβ strategies.
Pathological ECM deposition by activated fibroblasts/myofibroblasts. Impairs organ function (liver cirrhosis, pulmonary fibrosis, cardiac remodelling). Anti-TGFβ strategies.